Darwin Global Management, Ltd. has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $827 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $248M, Insmed Inc with a value of $237M, Vaxcyte, Inc. with a value of $157M, Geron Corp with a value of $101M, and Keros Therapeutics, Inc. with a value of $69.7M.

Examining the 13F form we can see an increase of $240M in the current position value, from $586M to 827M.

Darwin Global Management, Ltd. is based out at St. Helier, Y9

Below you can find more details about Darwin Global Management, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $827 Million
Healthcare: $827 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $827 Million
  • Prior Value $586 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 5 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.